PDA
5
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Ibuprofen
Research Leaders
6 sponsors active, led by Hillel Yaffe Medical Center
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure
The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.
Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants
NIRS in PDA VLBW Infants
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
Research Network
Common Treatments
- Ibuprofen2
- Near Infrared Red Spectroscopy Nirs1
- Acetaminophen1
- Closure Of Pda1
- Echocardiography Guide1
Active Sponsors
- Hillel Yaffe Medical Center1
- Pediatrix1
- Singapore General Hospital1
- China Medical University Hospital1
- Banner University Medical Center1
Top Investigators
China Medical University Hospital
National CCHK
Hillel Yaffe medical center, Hadera, Israel
Singapore General Hospital
Related Conditions
- Extremely Premature Infants1
- Low Birthweight Extremely 999 Grams Or Less1
- Oral Ibuprofen1
- Iv Ibuprofen1
- Echocardiography1